Menu
Scientists have shown that one of the non-psychoactive cannabinoids in cannabis – CBD – reduces lung damage caused by cytokine storms in COVID-19 patients.
This new study has now shown the mechanisms behind these results, demonstrating that CBD normalises levels of a peptide named apelin, which is known to reduce inflammation. Levels of this peptide are low during a COVID-19 infection.
The next steps in the research include better understanding the interaction between CBD, apelin, and the novel coronavirus, including why apelin goes down in the face of the virus and why CBD brings it up.
The researchers will be exploring how eliminating apelin affects ARDS and if CBD produces the same lung benefit without apelin. The authors note that it is likely the virus suppresses something that suppresses apelin and that CBD interferes with this process, however, they also they doubt the apelin-CBD interaction is the only way the compound works in this and other scenarios.
Read more at healtheuropa.eu
NB: Please Google whatever disease you have – along with Cannabis Oil – and see for yourself how effective it is in the search results.
